Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	38.09B -25.2%
Revenue (ttm)	16.64B -7.2%
Net Income	1.08B -22.1%
EPS	0.79 -22.1%
Shares Out	1.37B
PE Ratio	35.33
Forward PE	26.81
Dividend	1.00 (3.65%)
Ex-Dividend Date	n/a

Volume	9,088,782
Average Volume	5,064,394
Open	27.50
Previous Close	27.39
Day's Range	27.48 - 28.16
52-Week Range	27.18 - 38.36
Beta	0.26
RSI	44.02
Earnings Date	Apr 30, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverag...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,284
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2025, Beijing Tongrentang's revenue was 17.26 billion, a decrease of -7.21% compared to the previous year's 18.60 billion. Earnings were 1.19 billion, a decrease of -22.07%.